 6-Ketoprostaglandin F1 alpha
"6-Ketoprostaglandin F1 alpha" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue.
| Descriptor ID |
D015121
|
| MeSH Number(s) |
D10.251.355.255.550.400.350 D10.251.355.325.450 D23.469.050.175.725.400.350
|
| Concept/Terms |
6-Ketoprostaglandin F1 alpha- 6-Ketoprostaglandin F1 alpha
- F1 alpha, 6-Ketoprostaglandin
- alpha, 6-Ketoprostaglandin F1
- 6-Oxoprostaglandin F1 alpha
- 6 Oxoprostaglandin F1 alpha
- F1 alpha, 6-Oxoprostaglandin
- alpha, 6-Oxoprostaglandin F1
- 6-Oxo-PGF1 alpha
- 6 Oxo PGF1 alpha
- alpha, 6-Oxo-PGF1
- 6 Ketoprostaglandin F1 alpha
- 6-Keto-PGF1 alpha
- 6 Keto PGF1 alpha
- alpha, 6-Keto-PGF1
|
Below are MeSH descriptors whose meaning is more general than "6-Ketoprostaglandin F1 alpha".
Below are MeSH descriptors whose meaning is more specific than "6-Ketoprostaglandin F1 alpha".
This graph shows the total number of publications written about "6-Ketoprostaglandin F1 alpha" by people in this website by year, and whether "6-Ketoprostaglandin F1 alpha" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 | | 2002 | 1 | 1 | 2 | | 2004 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "6-Ketoprostaglandin F1 alpha" by people in Profiles.
-
Larsen GL, Loader J, Fratelli C, Kang JK, Dakhama A, Colasurdo GN. Modulation of airway responses by prostaglandins in young and fully grown rabbits. Am J Physiol Lung Cell Mol Physiol. 2007 Jul; 293(1):L239-44.
-
Nana-Sinkam P, Golpon H, Keith RL, Oyer RJ, Sotto-Santiago S, Moore MD, Franklin W, Nemenoff RA, Geraci MW. Prostacyclin in human non-small cell lung cancers. Chest. 2004 May; 125(5 Suppl):141S.
-
Meyer AM, Dwyer-Nield LD, Hurteau GJ, Keith RL, O'Leary E, You M, Bonventre JV, Nemenoff RA, Malkinson AM. Decreased lung tumorigenesis in mice genetically deficient in cytosolic phospholipase A2. Carcinogenesis. 2004 Aug; 25(8):1517-24.
-
Ivy DD, Yanagisawa M, Gariepy CE, Gebb SA, Colvin KL, McMurtry IF. Exaggerated hypoxic pulmonary hypertension in endothelin B receptor-deficient rats. Am J Physiol Lung Cell Mol Physiol. 2002 Apr; 282(4):L703-12.
-
Colgan SP, Taylor CT, Narravula S, Synnestvedt K, Blume ED. Endothelial COX-2 induction by hypoxia liberates 6-keto-PGF1 alpha, a potent epithelial secretagogue. Adv Exp Med Biol. 2002; 507:107-12.
-
Bauer AK, Dwyer-Nield LD, Hankin JA, Murphy RC, Malkinson AM. The lung tumor promoter, butylated hydroxytoluene (BHT), causes chronic inflammation in promotion-sensitive BALB/cByJ mice but not in promotion-resistant CXB4 mice. Toxicology. 2001 Dec 01; 169(1):1-15.
-
Blume ED, Taylor CT, Lennon PF, Stahl GL, Colgan SP. Activated endothelial cells elicit paracrine induction of epithelial chloride secretion. 6-Keto-PGF1alpha is an epithelial secretagogue. J Clin Invest. 1998 Sep 15; 102(6):1161-72.
-
Panos RJ, Voelkel NF, Cott GR, Mason RJ, Westcott JY. Alterations in eicosanoid production by rat alveolar type II cells isolated after silica-induced lung injury. Am J Respir Cell Mol Biol. 1992 Apr; 6(4):430-8.
-
McCormack JE, Kappler J, Marrack P, Westcott JY. Production of prostaglandin E2 and prostacyclin by thymic nurse cells in culture. J Immunol. 1991 Jan 01; 146(1):239-43.
-
Graham LM, Vasil A, Vasil ML, Voelkel NF, Stenmark KR. Decreased pulmonary vasoreactivity in an animal model of chronic Pseudomonas pneumonia. Am Rev Respir Dis. 1990 Jul; 142(1):221-9.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|